Skip to main content

Beam Therapeutics Inc 8-K, filed Nov 3, 2026

Beam Therapeutics Inc. (BEAM)

8-K 2026-11-03 For: 2026-11-03
View Original
Added on November 03, 2026

About this 8-K

Beam Therapeutics Inc filed this 8-K on November 3, 2026.

Beam Therapeutics expects to submit risto-cel's BLA as early as year-end 2026. It ended the third quarter with $1.0 billion in cash, cash equivalents and marketable securities, with runway expected into mid-2029. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits